Search company, investor...

Founded Year



Series D | Alive

Total Raised


Last Raised

$323.24M | 7 mos ago

About Neuralink

Neuralink focuses on the development of brain-computer interfaces. The company's main product is a fully implantable brain-computer interface designed to restore autonomy to individuals with unmet medical needs, such as quadriplegia, by enabling them to control computers and mobile devices with their thoughts. It primarily serves the medical technology and neuroscience sectors. It was founded in 2016 and is based in Fremont, California.

Headquarters Location

7400 Paseo Padre Parkway

Fremont, California, 94555,

United States



ESPs containing Neuralink

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Assistive & Implants Tech

The medical brain-computer interfaces (BCIs) market offers innovative solutions for patients with neurological disorders. BCIs are devices that allow direct communication between the brain and an external device, such as a computer or prosthetic limb. This technology has the potential to revolutionize the way we treat conditions such as paralysis, epilepsy, and Parkinson's disease. BCIs can also b…

Neuralink named as Leader among 7 other companies, including Synchron, Precision Neuroscience, and Blackrock Neurotech.


Research containing Neuralink

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Neuralink in 2 CB Insights research briefs, most recently on Sep 6, 2022.

Neuralink Patents

Neuralink has filed 30 patents.

The 3 most popular patent topics include:

  • implants (medicine)
  • neuroprosthetics
  • integrated circuits
patents chart

Application Date

Grant Date


Related Topics




Image processing, Surgery, Feature detection (computer vision), Computer vision, 3D imaging


Application Date


Grant Date



Related Topics

Image processing, Surgery, Feature detection (computer vision), Computer vision, 3D imaging



Latest Neuralink News

Neuralink's first human patient able to control mouse through thinking, Musk says

Feb 20, 2024

Neuralink's first human patient able to control mouse through thinking, Musk says February 20, 2024 at 03:19 am EST Share Feb 20 (Reuters) - The first human patient implantedwith a brain-chip from Neuralink appears to have fully recoveredand is able to control a computer mouse using their thoughts,the startup's founder Elon Musk said late on Monday. "Progress is good, and the patient seems to have made a fullrecovery, with neural effects that we are aware of. Patient isable to move a mouse around the screen by just thinking," Musksaid in a Spaces event on social media platform X. Musk said Neuralink was now trying to get as many mousebutton clicks as possible from the patient. Neuralink did not immediately reply to Reuters' request forfurther details. The firm successfully implanted a chip on its first humanpatient last month, after receiving approval for human trialrecruitment in September. The study uses a robot to surgically place a brain-computerinterface implant in a region of the brain that controls theintention to move, Neuralink has said, adding that the initialgoal is to enable people to control a computer cursor orkeyboard using their thoughts. Musk has grand ambitions for Neuralink, saying it wouldfacilitate speedy surgical insertions of its chip devices totreat conditions like obesity, autism, depression, andschizophrenia. Neuralink, which was valued at about $5 billion last year,has faced repeated calls for scrutiny regarding its safetyprotocols. Reuters reported last month that the firm was finedfor violating U.S. Department of Transportation rules regardingthe movement of hazardous materials. (Reporting by Kanjyik Ghosh in Bengaluru; Editing by Varun H K) Share

Neuralink Frequently Asked Questions (FAQ)

  • When was Neuralink founded?

    Neuralink was founded in 2016.

  • Where is Neuralink's headquarters?

    Neuralink's headquarters is located at 7400 Paseo Padre Parkway, Fremont.

  • What is Neuralink's latest funding round?

    Neuralink's latest funding round is Series D.

  • How much did Neuralink raise?

    Neuralink raised a total of $679.7M.

  • Who are the investors of Neuralink?

    Investors of Neuralink include Founders Fund, Valor Equity Partners, Robert Nelsen, Fred Ehrsam, Type One Ventures and 12 more.

  • Who are Neuralink's competitors?

    Competitors of Neuralink include Kernel, .lumen, Paradromics, Synchron, Neurosity and 7 more.


Compare Neuralink to Competitors

Kernel Logo

Kernel focuses on neuroscience, operating within the healthcare and technology sectors. The company's main offerings include proprietary neurotechnology used to build a portfolio of brain-based biomarkers, accelerate treatment discovery, improve patient outcomes, and transform neuro medicine. Kernel primarily serves the healthcare industry, specifically the neuro medicine sector. It was founded in 2016 and is based in Culver City, California.

Blackrock Neurotech Logo
Blackrock Neurotech

Blackrock Neurotech is a company focused on the development of neurotechnology, specifically in the field of implantable brain-computer interfaces. The company's main offerings include devices that restore function and independence to individuals with neurological disorders, enabling them to perform tasks such as eating, drinking, sending emails, and operating robotic arms using their thoughts. Blackrock Neurotech primarily serves the healthcare and research sectors, with a particular focus on neurological disorders and paralysis. It was founded in 2008 and is based in Salt Lake City, Utah.

Synchron Logo

Synchron operates as a medical device company. It focuses on the development of minimally invasive neuromodulation technology solutions. It develops an endovascular brain-computer interface to access every corner of the brain using the blood vessels. It offers switch device to help paralyzed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds. The company was founded in 2016 and is based in Brooklyn, New York.

Paradromics Logo

Paradromics provides data-rate brain-computer interfaces (BCI). It aims to enable treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation and spinal cord injuries. The company was founded in 2015 and is based in Austin, Texas.

Neurable Logo

Neurable develops brain-computer interface (BCI) technology. It uses electroencephalogram (EEG) activity and builds an intelligent layer between the brain and computers. It focuses on building hardware and devices to measure brain activity and provide actionable insights. The company was founded in 2016 and is based in Boston, Massachusetts. .


NURO develops a neurological platform allowing non-invasive communication and computing control by the brain. It permits any human being to communicate and compute through the brain. The company was founded in 2017 and is based in Waterloo, Canada.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.